GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Althea Group Holdings Ltd (OTCPK:AHGHF) » Definitions » Sloan Ratio %

Althea Group Holdings (Althea Group Holdings) Sloan Ratio % : -51.34% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Althea Group Holdings Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Althea Group Holdings's Sloan Ratio for the quarter that ended in Dec. 2023 was -51.34%.

As of Dec. 2023, Althea Group Holdings has a Sloan Ratio of -51.34%, indicating there is a warning stage of accrual build up.


Althea Group Holdings Sloan Ratio % Historical Data

The historical data trend for Althea Group Holdings's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Althea Group Holdings Sloan Ratio % Chart

Althea Group Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Sloan Ratio %
-4.64 25.07 -4.08 -3.69 -12.30

Althea Group Holdings Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -3.20 -3.72 -9.10 -12.34 -51.34

Competitive Comparison of Althea Group Holdings's Sloan Ratio %

For the Drug Manufacturers - Specialty & Generic subindustry, Althea Group Holdings's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Althea Group Holdings's Sloan Ratio % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Althea Group Holdings's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Althea Group Holdings's Sloan Ratio % falls into.



Althea Group Holdings Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Althea Group Holdings's Sloan Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Sloan Ratio=(Net Income (A: Jun. 2023 )-Cash Flow from Operations (A: Jun. 2023 )
-Cash Flow from Investing (A: Jun. 2023 ))/Total Assets (A: Jun. 2023 )
=(-9.211--4.224
--0.998)/32.443
=-12.30%

Althea Group Holdings's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(-14.061--1.875
-0.882)/25.456
=-51.34%

For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data. Althea Group Holdings's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was -2.93 (Jun. 2023 ) + -11.131 (Dec. 2023 ) = $-14.06 Mil.
Althea Group Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was -0.615 (Jun. 2023 ) + -1.26 (Dec. 2023 ) = $-1.88 Mil.
Althea Group Holdings's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -0.862 (Jun. 2023 ) + 1.744 (Dec. 2023 ) = $0.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Althea Group Holdings  (OTCPK:AHGHF) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Althea Group Holdings has a Sloan Ratio of -51.34%, indicating there is a warning stage of accrual build up.


Althea Group Holdings Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Althea Group Holdings's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Althea Group Holdings (Althea Group Holdings) Business Description

Traded in Other Exchanges
Address
360 Elizabeth Street, Suite 2, Level 50, Melbourne, VIC, AUS, 3000
Althea Group Holdings Ltd is engaged in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. It operates in three reportable segments Pharmaceutical Cannabis, Recreational Cannabis, and Corporate in which it generates the majority of its revenue from Pharmaceutical Cannabis. It operates into four geographic segments: Australia, the United Kingdom, Canada, and others. The company earns key revenue from Australia and through the sale of medicinal cannabis products.

Althea Group Holdings (Althea Group Holdings) Headlines